$APH

Do Wall Street Analysts Like Amphenol Stock?

Amphenol (APH) is covered by 17 analysts, with 15 rating it “Strong Buy” and two “Hold,” versus 14 “Strong Buy” three months ago. UBS’s Joseph Spak raised its price target to $197 from $185 and kept a Buy rating after Amphenol’s Q2 results beat EPS and revenue forecasts. The average target is $197.35, implying 19.1% upside.

Original reporting
Published Aug 15, 2026, 9:45 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 15, 2026, 9:53 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Do Wall Street Analysts Like Amphenol Stock? — source image
Decision brief

The 30-second read

$APHBullishLow
01

Why it matters

The incremental trading signal is the PT revision and the stated demand drivers (AI, data center, defense), which can influence short-term positioning but is not a new corporate disclosure.

02

Market read

Bullish sell-side sentiment is reinforced by a fresh PT increase tied to Q2 beats, but the article lacks new forward-looking company guidance.

03

What to watch

The article does not quantify margin, backlog, or forward order trends, so traders may need to verify whether Q2 strength is sustainable into the next quarters.

Relevance 4/10Novelty 4/10Timing: today’s analyst-target update (pre-market context)

Background

The piece is a sentiment/ratings roundup focused on Amphenol’s analyst coverage and a specific UBS price-target increase after Q2 results.

Company-level read

Ticker impact

$APHBullishMedium confidence
Context

Article says UBS raised Amphenol’s price target to $197 from $185 after Q2 results beat EPS and revenue forecasts, citing AI, data center, and defense demand.

Expected impact

Near-term bias modestly positive as the new PT and “Strong Buy” skew can support momentum, but it is still analyst-driven rather than a new company disclosure.

Evidence & confidence

The only new, concrete fact is the UBS PT increase and the article’s framing of Q2 beats; it does not add new financial guidance, contracts, or regulatory developments beyond what the results already implied.

Market effects

Supports sentiment for industrial/electronics interconnect exposure to AI and data-center capex themes, but no new sector datapoint is provided.

No specific regional market catalyst beyond US sell-side sentiment.

No direct global macro or international transaction details.

Counterpoint

Analyst PT hikes can lag or overstate fundamentals; without new guidance or incremental orders, the upside may already be priced in.

Key entities

  • Amphenol

    Subject of the article, with UBS raising its price target after Q2 results beat forecasts.

  • UBS

    Raised Amphenol’s price target to $197 from $185 and kept a Buy rating.

Related articles

$APHMedAI 8/10

APH's Communications Growth Surges: Can Rivals Dent Its Momentum?

Amphenol (APH) reported strong Q2 2026 growth, with Communications Solutions revenue up 85% YoY, driven by AI-related IT datacom demand. IT datacom accounted for 43% of sales, growing 89% YoY. APH expects Q3 sales of $9.3-$9.4B and EPS of $1.40-$1.42. Rivals TE Connectivity (TEL) and Bel Fuse (BELFB) also show growth in AI connectivity.

$FNMedAI 8/10

Fabrinet Drops After Earnings Dragging Down Peers Like Marvell and Amphenol

Fabrinet (FN) fell 20% after reporting Q4 revenue of $1.316B and EPS of $4.10, but Q1 guidance was seen as decelerating. This dragged down peers like Marvell (MRVL, -8%), Amphenol (APH, -7%), Coherent (COHR, -12%), and Lumentum (LITE, -10%). Anthropic's lower-than-expected ARR and 30-year Treasury yields also contributed to the sell-off in AI hardware stocks.

$APHHighAI 9/10

Amphenol (APH) Q2 2026 Earnings Call Transcript

Amphenol (APH) reported Q2 2026 net sales of $8.8 billion, up 55% in U.S. dollars and 30% organically year over year. Adjusted diluted EPS was $1.35. Record orders were $10.7 billion (book-to-bill 1.23). The company raised 2026 CommScope sales guidance to $4.6 billion and accretion to $0.30, and guided Q3 sales to $9.3-$9.4 billion.

$APHMed

Tech M&A Deals: Amphenol, Net at Work and Zedcrest Group

Today’s technology M&A activity includes acquisitions by Amphenol, Net at Work, and Zedcrest Group, expanding compliance testing technologies, managed IT and cybersecurity services, and cross-border payment infrastructure. Amphenol Acquires Wilder Technologies Amphenol announced the acquisition of Wilder Technologies, a U.S.-based manufacturer of compliance testing equipment for high-speed data communications and optical interconnects.